Treatment guidelines
Frequently used local treatment guidelines
On this page
Listed below are a number of frequently used local treatment guidelines.
Please use the search function above if the guideline you require is not listed.
Alternatively, search for treatment guidelines hosted on the GHNHSFT intranet (intranet access required).
Gastrointestinal System
- Andexanet alfa (Ondexxya®) for reversing rivaroxaban or apixaban in acute, life-threatening G.I. bleeds
- Ciclosporin for acute severe Ulcerative Colitis
- Clopidogrel / PPI interaction
- High Output Stoma
- Inflammatory Bowel Disease (IBD) Biologics Pathway
- Infliximab
- Laxative Guideline
- Proton Pump Inhibitors (PPI) - Oral
- Proton Pump Inhibitors (PPI) - Intravenous
- Terlipressin for variceal bleeding / hepato-renal syndrome
Cardiovascular System
- Acute Coronary Syndrome (ACS)
- Adenosine infusion (for Fractional Flow Reserve testing)
- Amiodarone
- Andexanet alfa (Ondexxya®) for reversing rivaroxaban or apixaban in acute, life-threatening G.I. bleeds
- Anticoagulants (oral) - management of bleeding
- Anticoagulants – switching
- Antiplatelets
- Cancer Associated Thrombosis
- Clopidogrel / PPI interaction
- Contrast-induced Nephropathy Prophylaxis
- DC cardioversion for AF on CCU
- Digoxin - being updated
- Digoxin overdose - DigiFab
- Direct Oral Anticoagulant (DOAC) 'Bridging' Protocol - Management of DOACs / NOACs During Elective Procedures
- DOAC choice
- DOAC reversal for acute, life-threatening bleeds
- Dobutamine infusion
- Fluid Resuscitation - intranet
- Fondaparinux
- GTN infusion chart
- HbA1c testing and glucose control in ACS
- Heparin (unfractionated) infusion
- Idarucizumab (Praxbind®) for reversing dabigatran in acute, life-threatening bleeds
- Iloprost for Critical Ischaemia or Severe Raynaud’s Phenomenon - intranet
- Inclisiran
- Labetalol infusion chart - intranet
- Lipid Pathway (secondary prevention)
- Noradrenaline (peripheral infusion)
- Post-Carotid Endarterectomy Hypertension management
- Prasugrel
- Prophylaxis/Treatment of VTE in COVID-19
- Prophylaxis/Treatment of VTE in renal impairment
- Statin Guideline
- Thrombolysis options during Alteplase shortage
- Thrombolysis of Massive Pulmonary Embolus (PE) - intranet
- Thrombolysis of STEMI (contingency 2020)
- Ticagrelor
- Tirofiban
- Warfarin Initiation
- Warfarin 'Bridging' Protocol - Management of Warfarin During Elective Procedures
- Warfarin: Management of high INR or bleeding
Respiratory System
- Aminophylline Infusion Chart
- Asthma inhaler guideline
- COPD inhaler guideline
- Intrapleural Fibrinolytics for Pleural Infection (alteplase & dornase alfa)
- Pulmonary Embolism - intranet
- Thrombolysis of Massive Pulmonary Embolus (PE) - intranet
- Non-Invasive Ventilation for Acute Hypercapnic Respiratory Failure - intranet
- High Flow Nasal Oxygen - intranet
- Tuberculosis screening for Biologic and Immunomodulatory drugs for inflammatory conditions
Nervous System
- ADHD Medication Supply Shortage
- Alcohol Detoxification - intranet
- Anti-emetics choice of therapy (paediatric) - intranet
- Apomorphine in Parkinson's Disease
- Dementia agitation pathway - G-Care
- Domperidone - MHRA restrictions
- Emergency Sedation (formerly Rapid Tranquillisation) - intranet
- Ketamine (multimodal analgesia) - intranet
- MAOI Diet Restrictions Advice
- Morphine Allergy - Pain Treatment - intranet
- Naloxone - intranet
- Neuropathic Pain - being updated
- Nicotine Replacement Therapy (NRT) - inpatients (non-pregnant)
- Nicotine Replacement Therapy (NRT) - inpatients (pregnant)
- Opioid Equivalence Chart
- Management of Opioid Users (inpatients) - intranet
- Pain Formulary
- Paracetamol (i.v.) prescribing criteria
- Paracetamol: Weight-adjusted dosing (adults)
- Parkinson's Disease - Medicines Management in Inpatients
- Post-operative Nausea & Vomiting (PONV) - intranet
- Status Epilepticus - intranet
Infection
- Antibiotic Guidelines
- MRSA Guideline (GHNHSFT) - intranet
- Splenectomy - intranet
Endocrine System
- Type 2 Diabetes Treatment Guideline - being updated
- Diabetic Ketoacidosis - intranet
- Hypoglycaemia - intranet
- Insulin Formulary
- Insulin Substitution
- Peri-operative Diabetes Management - intranet
- Corticosteroid Perioperative Management
- Corticosteroid Withdrawal
- Osteoporosis Guideline
- Short Synacthen Test
Genito-urinary System
Immune System and Malignant Disease
- Anaemia and Iron Deficiency in Oncology Patients
- Cancer Associated Thrombosis
- Cytokine Release Syndrome Treatment Guideline
- Darbepoetin Alfa for anaemia in patients receiving chemotherapy
- Anaemia and Iron Deficiency in Oncology Patients
- Glucarpidase for methotrexate-induced renal dysfunction
- Immune-related Diarrhoea & Colitis
- Methylthioninium chloride (Proveblue) for ifosfamide induced encephalopathy [previously known as 'methylene blue']
- Management of Immune-related Adverse Events (IrAEs) Caused by immunotherapy
- Management of Skin Toxicity Related to Parenteral Anti-EGFR Treatment for Colorectal Cancer
- Mosunetuzumab Treatment Guideline
- Tebentafusp for the Treatment of Metastatic Uveal Melanoma in HLA-A*02:01 Positive Patients
- Tumour Lysis Syndrome - intranet
- Prescription & Monitoring of High Dose Corticosteroids in Oncology Inpatients
Blood and Nutrition
- Hypercalcaemia (tumour-induced)
- Hypocalcaemia
- Hyperkalaemia
- Hypokalaemia
- Hypomagnesaemia
- Hyponatraemia
- Hypophosphataemia
- Cosmofer® (iron dextran) total dose infusion guideline
- Cosmofer® (iron dextran) administration - see Medusa or sample drug chart
- Diafer® (iron isomaltose) administration - see Medusa
- Ferinject® (ferric carboxymaltose) administration - see Medusa or sample drug chart
- Monofer® (iron[III] isomaltoside 1000) administration - see Medusa or sample drug chart
- Feraccru® (ferric maltol)
- Preoperative management of anaemia
- Anaemia and Iron Deficiency in Oncology Patients
- Vitamin B12 deficiency treatment
- Vitamin D deficiency treatment
- Vitamin D Rapid Loading: Bone Health Specialist Protocol - Inpatient use only
- Vitamins / Minerals Policy
- Intravenous Fluid Management – intranet
- Plerixafor - stem cell mobilisation
Musculoskeletal System
Eye
Ear, nose and oropharynx
- Mouthcare Guideline - intranet
Skin
Vaccines
Anaesthesia
Transfusion Medicine
- Blood Transfusion Policy (intranet)
- Management of Major Haemorrhage SOP – including Action Cards for ACRT, Porters, Site Team and Emergency Theatre Co-ordinator
- Running a ROTEM
- ROTEM interpretation algorithm
- Transfusion Reactions (intranet)
- Special requirements for transfusion (intranet)
- Direct Oral Anticoagulant (DOAC) Reversal guideline
- Human Prothrombin Complex Concentrate (PCC) guidance (Octaplex®)
- Patients who refuse blood and blood components
Miscellaneous
- Anticholinergic Burden Tool
- Creatinine Clearance Calculator
- Deprescribing in Frailty
- Emergency Drug Dose Cards
- End of Life Care - Prescribing Guidance
- Emergency Department adult guidelines (intranet)
- Emergency Department paediatric guidelines (intranet)
- Emergency Department Antidotes List
- Paediatric Department Guidelines (intranet)